EUVIMEDEUVIMED entdecken
Open Access

Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer

Jinhui Che, Zhiyuan Chen, Feng Zhang, Shuo Zhu, Shengya Cao, Ou Li, Rong Li, Jun Zheng, Yubin Liu

Oncology Research · 2026 · 34 (7) · 1-10

DOI: 10.32604/or.2026.067443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Jinhui Che und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, So…. Hauptthemen laut MEDLINE: Sorafenib, Dynamins, Liver Neoplasms, Drug Resistance, Neoplasm. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibDynaminsLiver NeoplasmsDrug Resistance, NeoplasmGlucoseCarcinoma, HepatocellularHumansAnimalsMiceMitochondrial DynamicsXenograft Model Antitumor AssaysQuinazolinonesCell Line, TumorCell ProliferationOxidative PhosphorylationMaleMitochondriaFemaleCell Movement

Stichwörter der Autor:innen

IACS-010759Sorafenib-resistant hepatocellular carcinomaglucose metabolismmdivi-1mitochondrial dynamics

Substanzen

SorafenibDynaminsDNM1L protein, humanGlucose3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinoneQuinazolinones

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Department of General Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou, China.
  • Department of Hepatic Surgery and Liver Transplantation Center of the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Guangdong Key Laboratory of Liver Disease Research, Key Laboratory of Liver Disease Biotherapy and Translational Medicine of Guangdong Higher Education Institutes, the Third Affiliated Hospital of Sun Yat-sen University…
  • Department of Clinical Laboratory, Xuzhou Cancer Hospital, Xuzhou, China.

Zitieren

APA

Che, J., Chen, Z., Zhang, F., Zhu, S., Cao, S., Li, O., Li, R., Zheng, J., & Liu, Y. (2026). Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.067443

Vancouver

Che J, Chen Z, Zhang F, Zhu S, Cao S, Li O, et al. Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.067443

BibTeX
@article{Che2026,
  author = {Che, Jinhui and Chen, Zhiyuan and Zhang, Feng and Zhu, Shuo and Cao, Shengya and Li, Ou and Li, Rong and Zheng, Jun and Liu, Yubin},
  title = {Targeting Dynamin-Related Protein 1 and Glucose Metabolism Reverses Acquired Resistance to Sorafenib in Liver Cancer},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {7},
  pages = {1--10},
  doi = {10.32604/or.2026.067443}
}
Kostenlos starten →